Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Spondyloarthropathy

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    17 result(s) found for: Spondyloarthropathy. Displaying page 1 of 1.
    EudraCT Number: 2009-017998-37 Sponsor Protocol Number: AGO/2009/015 Start Date*: 2012-06-08
    Sponsor Name:Ghent University Hospital
    Full Title: Scintigraphic detection of tumor necrosis factor with radioactive labeled TNFα-blocker in patients with active rheumatoid arthritis and active axial and peripheric spondyloarthropathy.
    Medical condition: Patients with an active spondyloarthropathy and with an active rheumatoid arthritis; who were diagnosed according to the classic ACR-criteria (American College of Rheumatology) for rheumatoid arthr...
    Disease: Version SOC Term Classification Code Term Level
    19.0 10017947 - Gastrointestinal disorders 10011401 Crohn's disease PT
    19.0 100000004859 10052775 Spondyloarthropathies HLT
    19.0 100000004859 10039078 Rheumatoid arthropathies HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2008-006885-27 Sponsor Protocol Number: ADA-periSPA2008 Start Date*: 2009-04-21
    Sponsor Name:Clinical Immunology and Rheumatology
    Full Title: EFFICACY AND SAFETY OF ADALIMUMAB (HUMIRA®) IN PATIENTS WITH PERIPHERAL SPONDYLOARTHRITIS WITHOUT ANKYLOSING SPONDYLITIS OR PSORIATIC ARTHRITIS
    Medical condition: PERIPHERAL SPONDYLOARTHRITIS WITHOUT ANKYLOSING SPONDYLITIS OR PSORIATIC ARTHRITIS
    Disease: Version SOC Term Classification Code Term Level
    9.1 10051265 Spondyloarthropathy LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-014348-12 Sponsor Protocol Number: ASIM (IMM 08-0061) Start Date*: 2009-10-13
    Sponsor Name:Mikkel Østergaard
    Full Title: Helkrops MR, MR af sacroiliacaled og columna totalis og cirkulerende biomarkører hos patienter med spondylartritis i behandling med adalimumab (ASIM)
    Medical condition: Spondyloartritis
    Disease: Version SOC Term Classification Code Term Level
    12.1 10051265 Spondyloarthropathy LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2009-010643-14 Sponsor Protocol Number: M10-791 Start Date*: 2009-07-22
    Sponsor Name:Abbott GmbH & Co. KG
    Full Title: A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Axial Spondyloarthritis
    Medical condition: Active axial spondyloarthritis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10051265 Spondyloarthropathy LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) DE (Completed) GB (Prematurely Ended) CZ (Completed) ES (Completed) BE (Completed) NL (Completed)
    Trial results: View results
    EudraCT Number: 2014-003701-15 Sponsor Protocol Number: 20101228 Start Date*: 2015-05-01
    Sponsor Name:Amgen Inc.
    Full Title: A Randomized, Double-blind, Placebo-controlled Study With an Open Label Extension to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Axial Spondyloarthritis
    Medical condition: Axial Spondyloarthritis
    Disease: Version SOC Term Classification Code Term Level
    18.0 10028395 - Musculoskeletal and connective tissue disorders 10051265 Spondyloarthropathy PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended) ES (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2004-001113-33 Sponsor Protocol Number: AGO/REU/04/01 Start Date*: 2004-10-13
    Sponsor Name:University Hospital Ghent
    Full Title: Effect of TNFalpha blockade on the induction of specific B cell responses in vivo, using human spondyloarthropathy as model.
    Medical condition: Spondyloarthropathy
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-011719-19 Sponsor Protocol Number: AS001 Start Date*: 2010-03-29
    Sponsor Name:SCHWARZ BIOSCIENCES, GmbH, A Member of the UCB Group of Companies
    Full Title: PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF CERTOLIZUMAB PEGOL IN SUBJECTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS (AXIAL SPA)
    Medical condition: axial spondyloarthritis (axial SpA)
    Disease: Version SOC Term Classification Code Term Level
    12.1 10002557 Ankylosing spondylitis and other inflammatory spondylopathies LLT
    12.1 10051265 Spondyloarthropathy LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) DE (Completed) GB (Completed) HU (Completed) BE (Completed) IT (Completed) NL (Completed) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2019-004961-42 Sponsor Protocol Number: BC-6226 Start Date*: 2020-08-06
    Sponsor Name:Ghent University Hospital
    Full Title: SPondyloArthritis: inducing drug-free Remission by early TNF-Alpha bloCkade Under guidance of Single cell RNA sequencing and epigenetic profiling
    Medical condition: peripheral spondyloarthritis
    Disease: Version SOC Term Classification Code Term Level
    20.0 10028395 - Musculoskeletal and connective tissue disorders 10051265 Spondyloarthropathy PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-014567-39 Sponsor Protocol Number: M10-883 Start Date*: 2010-02-19
    Sponsor Name:AbbVie Deutschland GmbH & Co. KG
    Full Title: A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Peripheral Spondyloarthritis
    Medical condition: Peripheral Spondyloarthritis
    Disease: Version SOC Term Classification Code Term Level
    16.1 100000004859 10052775 Spondyloarthropathies HLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed) FR (Completed) BE (Completed) IE (Completed) HU (Completed) ES (Completed) CZ (Completed) GR (Completed)
    Trial results: View results
    EudraCT Number: 2010-020077-16 Sponsor Protocol Number: B1801031 Start Date*: 2010-12-22
    Sponsor Name:Pfizer, S.A
    Full Title: Estudio de 12 semanas de duración, multicéntrico, doble ciego, controlado con placebo, aleatorizado de etanercept con un AINE de base en el tratamiento de sujetos adultos con espondiloartritis axia...
    Medical condition: Espondiloartritis axial (AxSpA)
    Disease: Version SOC Term Classification Code Term Level
    12.1 10051265 Spondyloarthropathy LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed) HU (Completed) DE (Completed) BE (Completed) GB (Completed) DK (Prematurely Ended) NL (Completed) FI (Completed) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2011-003678-97 Sponsor Protocol Number: AGO/2011/005 Start Date*: 2011-11-09
    Sponsor Name:Ghent University Hospital
    Full Title: Exploration of TNF-alpha Blockade with golimumab in the Induction of Clinical Remission in Patients with Early peripheral SpondyloArthritis (SpA) according to ASAS-criteria (‘CRESPA’).
    Medical condition: Early stage peripheral Spondyloarthritis (SpA)
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004859 10056449 Spondyloarthrosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2013-003812-30 Sponsor Protocol Number: UP0017 Start Date*: 2014-07-21
    Sponsor Name:UCB Biosciences Inc.
    Full Title: A MULTICENTER POSTMARKETING STUDY TO EVALUATE THE PLACENTAL TRANSFER OF CERTOLIZUMAB PEGOL IN PREGNANT WOMEN RECEIVING TREATMENT WITH CIMZIA® (CERTOLIZUMAB PEGOL)
    Medical condition: Rheumatoid Arthritis Axial spondyloarthritis Psoriatic arthritis
    Disease: Version SOC Term Classification Code Term Level
    17.0 10028395 - Musculoskeletal and connective tissue disorders 10003268 Arthritis rheumatoid LLT
    17.0 10028395 - Musculoskeletal and connective tissue disorders 10037160 Psoriatic arthritis LLT
    17.0 10028395 - Musculoskeletal and connective tissue disorders 10051265 Spondyloarthropathy PT
    17.0 10028395 - Musculoskeletal and connective tissue disorders 10002557 Ankylosing spondylitis and other inflammatory spondylopathies LLT
    Population Age: Newborns, Infants and toddlers, Under 18, Adults Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2021-001256-34 Sponsor Protocol Number: CAIN457X12301 Start Date*: 2022-02-07
    Sponsor Name:Novartis Pharma AG
    Full Title: A randomized, parallel-group, double-blind, placebo-controlled, multicenter phase III study to investigate the efficacy and safety of secukinumab (Cosentyx) 300 mg administered subcutaneously in pa...
    Medical condition: Peripheral Spondyloarthritis
    Disease: Version SOC Term Classification Code Term Level
    24.1 10028395 - Musculoskeletal and connective tissue disorders 10085753 Peripheral spondyloarthritis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SK (Prematurely Ended) IT (Prematurely Ended) HU (Prematurely Ended) ES (Prematurely Ended) DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-001448-29 Sponsor Protocol Number: 30001 Start Date*: 2006-09-18
    Sponsor Name:St Georges Healthcare NHS trust
    Full Title: A prospective observational cohort study of intra-articular Infliximab in knee mono-arthritis
    Medical condition: Inflammatory knee mono-arthritis
    Disease: Version SOC Term Classification Code Term Level
    8.1 10062164 Seronegative arthritis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2011-000311-34 Sponsor Protocol Number: P07642 Start Date*: 2011-11-29
    Sponsor Name:Schering-Plough Research Institute, a Division of Schering Corporation
    Full Title: A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Effect of Golimumab Administered Subcutaneously in Subjects with Active Axial Spondyloarthritis (Phase 3b, Protocol No. P0...
    Medical condition: Active Axial Spondyloarthritis (SpA)
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004859 10041672 Spondylitis ankylosing LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed) ES (Completed) FI (Completed) IT (Completed) GR (Completed)
    Trial results: View results
    EudraCT Number: 2015-004020-65 Sponsor Protocol Number: MK-8259-038 Start Date*: 2017-07-20
    Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
    Full Title: A Phase-IV, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Evaluate the Efficacy and Safety of Golimumab (MK-8259 [SCH 900259]) After Treatment Withdrawal, Compared With Cont...
    Medical condition: Treatment of non-radiographic axial spondyloarthritis (nr-axSpA)
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004859 10076297 Non-radiographic axial spondyloarthritis LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed) CZ (Completed) ES (Completed) NL (Completed) PL (Completed) RO (Completed)
    Trial results: View results
    EudraCT Number: 2006-001579-40 Sponsor Protocol Number: P04440 Start Date*: 2007-04-02
    Sponsor Name:Schering-Plough France
    Full Title: Study of peripheral enthesitis with ultrasonography doppler in spondyloarthropathies treated with infliximab
    Medical condition: Spondyloarthropathies
    Disease: Version SOC Term Classification Code Term Level
    9.1 10002556 Ankylosing spondylitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Prematurely Ended) ES (Completed) DK (Prematurely Ended) HU (Prematurely Ended)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon May 20 03:47:45 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA